Genetic sequencing is the gold standard for diagnosing mitochondrial encephalomyopathies, preceded by non-invasive tests such as fibroblast growth factor-21 and growth differentiation factor-15. This evidence concerns the gene GDF15 and mitochondrial encephalomyopathy.